| 谈超,张升申,钱芳芳,等.血液透析病人并发高血压应用降压药物处方分析[J].安徽医药,2017,21(3):569-571. |
| 血液透析病人并发高血压应用降压药物处方分析 |
| Antihypertensive therapy for hemodialysis patients with hypertension |
| 投稿时间：2016-07-18 |
| DOI： |
| 中文关键词: 肾透析 抗高血压药 处方不当 |
| 英文关键词: Renal dialysis Antihypertensive agents Inappropriate prescribing |
| 基金项目: |
|
| 摘要点击次数: 2624 |
| 全文下载次数: 816 |
| 中文摘要: |
| 目的 调查血液透析病人并发高血压降压药物使用情况,探讨药物使用的合理性,为临床合理用药提供参考。 方法 收集某医院2015年1—3月血液透析病人高血压用药的电子处方,对各类药物的用药频率及联合用药情况进行分析。 结果 在含有高血压药物的处方中,最为常用的抗高血压药物依次为钙通道阻滞剂(CCB)、血管紧张素Ⅱ受体阻滞剂(ARB)、β-受体阻滞剂(β-RB)和血管紧张素转化酶抑制剂(ACEI)。抗高血压药应用频率最高为硝苯地平控释片,处方中采用单一用药进行降压的占44.00%,二联占30.00%,三联及其以上占26.00%。 结论 某医院血液透析病人并发高血压降压用药基本符合当前高血压治疗原则及个体化治疗方案,无滥用药物情况,但仍需提高用药的合理性。 |
| 英文摘要: |
| Objective To investigate the usage of antihypertensive medicine in hemodialysis patients,analyze the reasonableness of it ,and provide reference for the rational use of these drugs. Methods Electronic prescriptions were collected from patients data treated at the Affiliated Hospital of Anhui Medical University during January 2015 to March 2015.DDDs and drug combinations were analyzed. Results In prescriptions,CCB,ARB,ACEI and β-RB were more often used;Single drug rate in prescriptions was 44.00%,with 30.00% for double combination and 26.00% for triple and above combination. Conclusions The use of hypertension drugs was basically in line with the basic principles of treatment of hypertension and individualized treatment,however,it still needs to be improved. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
